Bionano Genomics (NASDAQ:BNGO) Stock Price Down 7.5% – Here’s What Happened

Bionano Genomics, Inc. (NASDAQ:BNGO)’s stock price was down 7.5% on Monday . The stock traded as low as $4.84 and last traded at $4.96. Approximately 138,101 shares changed hands during trading, a decline of 52% from the average daily volume of 288,391 shares. The stock had previously closed at $5.36.

Wall Street Analyst Weigh In

Separately, LADENBURG THALM/SH SH lowered Bionano Genomics from a “buy” rating to a “neutral” rating in a research note on Friday, November 15th.

Bionano Genomics Stock Down 7.5 %

The company has a current ratio of 1.43, a quick ratio of 0.99 and a debt-to-equity ratio of 0.07. The business has a 50-day moving average price of $9.91 and a 200-day moving average price of $17.55. The firm has a market cap of $9.69 million, a P/E ratio of -0.04 and a beta of 2.14.

Hedge Funds Weigh In On Bionano Genomics

Hedge funds and other institutional investors have recently made changes to their positions in the company. GSA Capital Partners LLP bought a new position in shares of Bionano Genomics during the 3rd quarter worth $46,000. Geode Capital Management LLC boosted its position in Bionano Genomics by 47.3% during the third quarter. Geode Capital Management LLC now owns 882,854 shares of the company’s stock valued at $401,000 after purchasing an additional 283,639 shares in the last quarter. Carret Asset Management LLC boosted its position in Bionano Genomics by 89.0% during the third quarter. Carret Asset Management LLC now owns 85,055 shares of the company’s stock valued at $39,000 after purchasing an additional 40,055 shares in the last quarter. Jane Street Group LLC bought a new stake in Bionano Genomics during the fourth quarter valued at about $118,000. Finally, Renaissance Technologies LLC bought a new stake in Bionano Genomics during the fourth quarter valued at about $46,000. Institutional investors own 11.35% of the company’s stock.

Bionano Genomics Company Profile

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.